Indications

Nervous System Disorders

  • 50+ clinical sites in Poland, Bulgaria
  • 50+ investigators in neurology and psychiatry
  • Pharmacokinetic trials
  • Experience with depot neuroleptics

Schizophrenia

Depression

  • two phase III trials in 280 patients

Cerebral Stroke

  • two phase III trials in 60 patients